Kimberly-Clark

KMB on Nasdaq. Kimberly-Clark sells diapers, tissues and personal care products to people worldwide. Market value $31.7bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Not a fit for our list right now

See Everyday goods stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to June 2026
5.7%fair

For every $100 of what the whole company costs, it produced $5.66 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to June 2026
15.0×full

You pay 15.0 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
23.3%five-year median

Each dollar kept in the business earns 23 cents a year. Above 10 is good.

Quality score: 57 of 100. Price score: 92 of 100. Our list needs 70 on quality and 60 on price.

$96.77 a share, 5% above its 1-year low

Over the past year the price has ranged from $92.42 to $123.09.

Dividend: 5.2% a year

Paid every year for at least 5 years

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

1.7
1.9
2.8
2.5
1.6
1.8
2021202220232024202512 monthsto Jun '26
Revenue
$19.4bn$20.2bn$17.1bn$16.8bn$16.4bn
Operating margin
13.2%13.3%11.2%16.1%14.3%
Debt to equity
16.6815.408.738.834.77
Shares outstanding
0.34bn0.34bn0.33bn0.33bn0.33bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)5 of 9
  • Profit backed by cash (accruals)Yes
  • Debt4.77× equity
  • Revenue growth, five yearsShrinking, 3.0% a year
  • Buying back its own sharesRoughly flat

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $4.2 billion last quarter, about the same as a year ago.
  • Profit: $345 million, down 32% on a year ago.
  • It keeps 15 cents of each $1 of sales as operating profit, down from 16 cents a year earlier.
  • Spare cash over the past 12 months: $1.8 billion, down from $2.1 billion.
  • About the same number of shares as a year ago.
  • Debt is $5.6 billion more than cash, down from $6.6 billion a year ago.
  • Sales grew on a year ago in 3 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$4.1bn
December 2024$4.1bn
March 2025$4.1bn
June 2025$4.2bn
September 2025$4.2bn
December 2025$4.1bn
March 2026$4.2bn
June 2026$4.2bn
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$907m
December 2024$447m
March 2025$567m
June 2025$509m
September 2025$446m
December 2025$499m
March 2026$665m
June 2026$345m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
3 November 2026
Last annual report (10-K)
12 February 2026
Next quarterly (estimated, 10-Q)
3 November 2026

Who owns it

12 long-term investors we follow own it, up from 11 last quarter. 1,705 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

3 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $1m of shares on the open market. 2 sold $1m.

  • Scribner Andrew
    Controller, VP & FP&A
    Sold
    Date
    6 May 2026
    Shares
    4,095
    Price
    $98.00
    Value
    $401,310
  • Chen Katy
    President, Int'l Personal Care
    Sold
    Date
    4 May 2026
    Shares
    1,596
    Price
    $95.34
    Value
    $152,163
  • Chen Katy
    President, Int'l Personal Care
    Sold
    Date
    30 April 2026
    Shares
    1,405
    Price
    $96.96
    Value
    $136,229
  • MACLIN TODD
    Director
    Bought
    Date
    9 February 2026
    Shares
    10,000
    Price
    $104.15
    Value
    $1m
  • Scribner Andrew
    Controller, VP & FP&A
    Sold
    Date
    5 February 2026
    Shares
    3,049
    Price
    $104.29
    Value
    $317,980

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 12 Feb 2026, plus the 10-Q filed 4 Aug 2026 and 6 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It carries a lot of debt: 4.8× its equity.
  • Sales have shrunk: 3.0% a year.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.